EMCURE PHARMA: KAZAKHSTAN STEP-DOWN SUBSIDIARY ACQUIRES 100% INTEREST OF DIALYSIS CENTER ALMATY LLP

• NEPHROPLUS HEALTH SERVICES KAZAKHSTAN LLP to acquire 100% participatory interest in Dialysis Center Almaty LLP. • Acquisition for an aggregate consideration of KZT 561.66 million (approx. ₹56.16 Cr), subject to downward adjustments. • Target Entity is engaged in providing dialysis services in Kazakhstan with 34 dialysis machines. • Target Entity's last audited turnover was KZT 527.44 million (approx. ₹52.74 Cr). • Acquisition aligns with the company's strategy of expanding its international dialysis services network.

Nephrocare Health Services Limited

Open attachment

← Back to feed